Galderma, a leading pharmaceutical company dedicated to advancing the future of dermatological and skin care products, is taking their marketing operations in a whole new direction by establishing its own team of marketing personnel, product specialists and brand representatives to engage with healthcare professionals and institutions directly.
This expansion plan is in line with the company's business strategy to consistently expand its synergistic portfolio of flagship brands, supported by science-based product differentiation and premium positioning to match consumer and patient needs with superior outcomes.
According to Cindy Tiu, Country Manager of Galderma Malaysia, the company will be focusing on broadening engagement sessions with healthcare professionals that are thought leadership in nature and is backed with dermatology science.
"Our goal is to continue supporting our strong growth trajectory with an enhanced focus that will significantly increase our ability to engage and better serve our healthcare community," said Cindy. "At Galderma, we understand that our skin shapes our lives. We are advancing dermatology for every skin story."
Galderma delivers an innovative, science-based portfolio of premium flagship brands and services that spans the full spectrum of the fast-growing dermatology market. Additionally, Galderma is known for its diverse portfolio of injectable technologies with over two decades of aesthetic innovation and experience from over 85 million treatments worldwide.
In 2022, Galderma delivered strong performance globally with 13.9% year-on-year net sales growth on a constant currency basis, driven by innovation and commercial performance. The sustained growth momentum was fueled by continued strong performance in Injectable Aesthetics and Dermatological Skincare.